You are here: Industry Insights > NHS

News List

People at high risk of diabetes fast-tracked into prevention programme pharmatimes
July 27, 2020
People at high risk of developing type II diabetes will be fast-tracked into the Healthier You NHS Diabetes Prevention programme, on the back of research indicating that people with the condition are at significantly higher risk of dying with COVID-19.
COVID-19 more severe in colder months, research suggests pharmatimes
July 24, 2020
Environmental temperature and humidity have an effect on the severity of COVID-19 symptoms, researchers from Europe and China have concluded.
Vertex and NHS Wales agree on Kaftrio reimbursement pharmatimes
July 23, 2020
People with cystic fibrosis (CF) living in Wales should get speedy access to Vertex' new therapy following its approval by Europe regulators.
Trainee GP numbers rise for third year running pharmatimes
July 22, 2020
New data released by Health Education England (HEE) show there were 3,441 GP specialty training places were accepted in 2020, compared to 2,891 a year ago.
PM to announce extra £3bn for NHS pharmatimes
July 20, 2020
Prime minister Boris Johnson is set to announce £3 billion in extra funding for the NHS to help it prepare for a second wave of coronavirus this winter.
NHS launches ‘Your COVID Recovery’ service pharmatimes
July 07, 2020
The NHS has launched a new on-demand service for tens of thousands of people suffering from the long-term effects of coronavirus.
King's researchers win £1m grant for COVID-19 research pharmatimes
July 07, 2020
A research team at King's College London led by Professor Michael Malim from the School of Immunology & Microbial Sciences has been awarded £1 million funding for research into COVID-19.
Vertex signs 'landmark' deal with NHS for CF therapy pharmatimes
July 01, 2020
Vertex has reached an agreement with NHS England to reimburse its triple combination therapy Kaftrio (ivacaftor/tezacaftor/elexacaftor) in combination with Kalydeco (ivacaftor), should the medicine win European approval.
Successful Eloctaq bid should widen access to the drug in the UK pharmatimes
June 30, 2020
The National Health Service (NHS) and Sobi UK have come to an agreement that will give people living with haemophilia A in the UK increased access to Eloctaq (efmoroctocog alfa), by lifting prior volume restrictions for the drug.
High-street pharmacist check-ups overshoot 300,000 pharmatimes
June 23, 2020
More than 300,000 NHS check-ups with a high-street pharmacists have taken place since October, highlighting the popularity and potential of the new scheme as a first-line stop for healthcare advice.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 44 45 Next page